Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Anagnostics logo — Pioneering systems and tests for research and clinical in-vi...

Anagnostics

Pioneering systems and tests for research and clinical in-vitro diagnostics to address unmet needs in protein and infectious disease diagnostics.

Founded 2005 Series Unknown Total: $3.79M Biotechnology, Health Care

General Information

Company Name Anagnostics
Founded Year 2005
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Anagnostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Anagnostics

Anagnostics is a pioneering company specializing in developing systems and tests for research and clinical in-vitro diagnostics. Established in 2005, the company focuses on addressing unmet needs, particularly in protein and infectious disease diagnostics. Anagnostics aims to provide innovative solutions in the biotechnology and healthcare industries through its cutting-edge technologies. The company received a significant €3.79M Venture Round investment from Tecnet Equity and PP Capital on 27th February 2009, showcasing investor confidence in the company's potential for growth and impact in the diagnostics field.

Taxonomy: In-vitro diagnostics, Protein diagnostics, Infectious disease diagnostics, Research, Clinical, Medical research, Laboratory testing, Diagnostic solutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 2
Investor Investor
27 Feb 2009
Venture Round •••••• 1 •••• •••• 01 Jan 2003

Anagnostics Alternatives & Competitors

Anagnostics vs
xMD Diagnostics, Inc.
xMD Diagnostics, Inc. United States

Enabling precision diagnostics

Non Equity Assistance
2 employees
Biotechnology, Health Care
Anagnostics vs
CORE Diagnostics
CORE Diagnostics India

trusted . innovative . diagnostics

Series Unknown
459 employees
Biotechnology, Health Care
Anagnostics vs
Labsystems Diagnostics Oy
Labsystems Diagnostics Oy Finland

Advance Diagnostics for the Gen-Next

45 employees
Manufacturing, Medical Devices

FAQ About Anagnostics

Pioneering systems and tests for research and clinical in-vitro diagnostics to address unmet needs in protein and infectious disease diagnostics.
Anagnostics was founded in 2005.
Anagnostics operates in the following industries: Biotechnology, Health Care.
Anagnostics has completed 2 funding rounds, raising a total of $3.79M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Anagnostics include xMD Diagnostics, Inc., CORE Diagnostics, Labsystems Diagnostics Oy, Revelation Biosciences Inc. , Safeguard Biosystems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Anagnostics and xMD Diagnostics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Anagnostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy